Press Release 2024 - Sami-Sabinsa Group | Formerly Known as Sami Labs Limited

Disclaimer

Please note that this website and information provided herein is not for final consumers of a finished food, beverage, dietary supplement product or cosmetic product, as the information contained herein does not refer to finished products for consumers.

The information provided on the website is intended only for producers of finished food, beverage, dietary supplement and cosmetic product.

The statements related to ingredients on the website, have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

The website and information herein are available in various countries across the world, and hence statements or product information including its classification may not be applicable in your country.

Information and statements provided on the website, shall not be construed as license to practice, or recommendations to infringe, any patents or other intellectual property rights of Sabinsa and others.

By browsing further, You understand the above terms.

Study Published on Safety and Tolerability of Sabinsa’s Sabeet® Beetroot Extract in Older Populations

Sabinsa’s LactoSpore® Found Safe and Effective for Children

Dr. Devaraj Reddy Joins the Sami-Sabinsa Group as Chief Operating Officer

High-Level Delegation from The Republic of Uzbekistan Visits Sami-Sabinsa Group for Potential Collaborations in Pharmaceutical Sector

USP Acknowledges Sami-Sabinsa for Reference Standards Contributions

Sami-Sabinsa Group’s Hassan Unit 1 Facility Certified as Meeting NSF cGMP Requirements

Certificates

Global Offices

Get in Touch

Disclaimer